SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — May 13, 2013
Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: May 13, 2013 · CIK: 0001446159 · Accession: 0001144204-13-028235
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-179145
Letter
Division of Corporation Finance Attention: Russell Mancuso Re: BioDrain Medical, Inc. (the “Company”) Registration Statement on Form S-1 Amendment No. 5 Filed May 10, File No. 333-179145
Dear Mr. Mancuso:
The undersigned respectfully requests that the Registration Statement on Form S-1 of BioDrain Medical, Inc. (SEC File No. 333-179145) be declared effective at 9:00 a.m., Washington, D.C. time, on Tuesday, May 14, 2013, or as soon thereafter as is practicable.
In connection with this request, the Company hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, such declaration does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any other person under the federal securities laws of the United States.
Sincerely,
BIODRAIN MEDICAL, INC.
Show Raw Text
CORRESP
1
filename1.htm
BioDrain
Medical, Inc.
2915 Commers Drive, Suite 900
Eagan, MN 55121
May 13, 2013
Transmitted via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Russell Mancuso
Re: BioDrain Medical, Inc. (the “Company”)
Registration Statement on Form
S-1
Amendment No. 5 Filed May 10,
2013
File
No. 333-179145
Dear Mr. Mancuso:
The undersigned respectfully requests that
the Registration Statement on Form S-1 of BioDrain Medical, Inc. (SEC File No. 333-179145) be declared effective at 9:00 a.m.,
Washington, D.C. time, on Tuesday, May 14, 2013, or as soon thereafter as is practicable.
In connection with this request, the Company
hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, such declaration
does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any other person under the federal securities laws of the United States.
Sincerely,
BIODRAIN MEDICAL, INC.
By:
/s/ Bob Myers
Bob Myers, Chief Financial Officer